TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31924158

Group type: EXPERIMENTAL
Intervention: Pomegranate juice with cyclosporine (100 mg cyclosporine + 500 ml pomegranate juice)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Water with cyclosporine (100 mg cyclosporine + 500 ml water)
Number of subjects: 14
Study: 29619799

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate, ketogenic diet (LC; <50 g/day and <10% of energy from carbohydrates)
Number of subjects: 16

Group type: COMPARATOR
Intervention: High-carbohydrate diet (HC; 6-10 g/kg/day carbohydrate)
Number of subjects: 16
Study: 28472219

Group type: COMPARATOR
Intervention: Folic Acid (FA)
Number of subjects: 18775

Group type: COMPARATOR
Intervention: Iron + Folic Acid (IFA)
Number of subjects: 18775

Group type: COMPARATOR
Intervention: Multiple Micronutrients (MMN)
Number of subjects: 18775

Group type: COMPARATOR
Intervention: Folic Acid (FA) before 12 weeks
Number of subjects: 18775

Group type: COMPARATOR
Intervention: Iron + Folic Acid (IFA) before 12 weeks
Number of subjects: 18775

Group type: COMPARATOR
Intervention: Multiple Micronutrients (MMN) before 12 weeks
Number of subjects: 18775

Group type: COMPARATOR
Intervention: Folic Acid (FA) after 12 weeks
Number of subjects: 18775

Group type: COMPARATOR
Intervention: Iron + Folic Acid (IFA) after 12 weeks
Number of subjects: 18775

Group type: COMPARATOR
Intervention: Multiple Micronutrients (MMN) after 12 weeks
Number of subjects: 18775
Study: 25229605

Group type: EXPERIMENTAL
Intervention: Static Active Stretching (SAS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dynamic Active Stretching (DAS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 36
Study: 24001080

Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) midazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous (IV) lorazepam
Number of subjects: 0
Study: 22204002

Group type: EXPERIMENTAL
Intervention: Patellar resurfacing during total knee arthroplasty
Number of subjects: 1715

Group type: COMPARATOR
Intervention: No patellar resurfacing during total knee arthroplasty
Number of subjects: 1715

Group type: EXPERIMENTAL
Intervention: Patellar resurfacing
Number of subjects: 1715

Group type: COMPARATOR
Intervention: No patellar resurfacing
Number of subjects: 1715
Study: 18302621

Group type: EXPERIMENTAL
Intervention: Tongue scraping
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Oral hygiene instruction/chlorhexidine + cetyl pyridinium gargling
Number of subjects: 72
Study: 16569890

Group type: EXPERIMENTAL
Intervention: Ritonavir (100 mg BID) with fosamprenavir (700 mg BID)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ritonavir (100 mg BID) with amprenavir (600 mg BID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fosamprenavir (700 mg BID) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amprenavir (600 mg BID) alone
Number of subjects: 0
Study: 12525383

Group type: EXPERIMENTAL
Intervention: Spa treatment
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Observational study
Number of subjects: 117
Study: 11185675

Group type: EXPERIMENTAL
Intervention: Digoxin 0.375 mg plus 8 mg rosiglitazone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Digoxin 0.375 mg plus matching placebo
Number of subjects: 0
Study: 8874587

Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1316077

Group type: EXPERIMENTAL
Intervention: Lomefloxacin 400 mg once daily for 10-14 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg every 12 hours for 10-14 days
Number of subjects: 150
Study: 2867576

Group type: EXPERIMENTAL
Intervention: IV naloxone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 24
Study: 31678959

Group type: EXPERIMENTAL
Intervention: Preoperative ultrasound‐guided ESPB with 0.5% ropivacaine
Number of subjects: 82

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 82
Study: 30577847

Group type: EXPERIMENTAL
Intervention: Participation in the peer-review network (active intervention, n=18)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control arm (delayed participation in the network, n=20)
Number of subjects: 38
Study: 26969218

Group type: EXPERIMENTAL
Intervention: Vdrive™ with V‐Loop™ system (remote navigation)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Manual navigation (control)
Number of subjects: 120
Study: 23421896

Group type: EXPERIMENTAL
Intervention: Automated advisor
Number of subjects: 148

Group type: COMPARATOR
Intervention: Human advisor
Number of subjects: 148
Study: 22154198

Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment for 6 months, titrated to 40 mg/d
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no atorvastatin treatment)
Number of subjects: 56
Study: 21198251

Group type: EXPERIMENTAL
Intervention: Training alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Task-switching dyads
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interdependent dyads
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partner-prompted metacognitive activity in interdependent dyads
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partner-prompted metacognitive activity in task-switching dyads
Number of subjects: 0
Study: 16708003

Group type: EXPERIMENTAL
Intervention: Audit and feedback and educational outreach
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Educational outreach
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Printed educational materials alone
Number of subjects: 1078
Study: 12854103

Group type: EXPERIMENTAL
Intervention: Ultrasonic dissection
Number of subjects: 200

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 200
Study: 10686268

Group type: EXPERIMENTAL
Intervention: Active rTMS (20 2-sec trains of 20 Hz stimulation with 58-sec intervals; delivered at 80% motor threshold over the left dorsolateral prefrontal cortex)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham rTMS (similar conditions with the coil elevated and angled 45 degrees tangentially to the scalp)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 20
Study: 9052303

Group type: EXPERIMENTAL
Intervention: Infusion group (Group I, n = 6)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Bolus injection group (Group II, n = 9)
Number of subjects: 15
Study: 8246028

Group type: COMPARATOR
Intervention: OND (ondansetron)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: ODC (ondansetron, dexamethasone, chlorpromazine)
Number of subjects: 44
Study: 3512534

Group type: EXPERIMENTAL
Intervention: Imipramine up to 200 mg/day (mean = 130 mg/day)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 12 weekly therapist‐assisted in vivo exposure sessions (flooding)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Imipramine plus flooding
Number of subjects: 62

Group type: COMPARATOR
Intervention: Systematic therapeutic instructions for self‐directed in vivo exposure (programmed practice)
Number of subjects: 62
Study: 30875548

Group type: EXPERIMENTAL
Intervention: Inconsistent and ambiguous evidence
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Transitive inference explanations
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Inconclusive evidence
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Problem-solving accuracy
Number of subjects: 363
Study: 29704557

Group type: EXPERIMENTAL
Intervention: Mabfilin and Fabfilin molecules
Number of subjects: 0
Study: 24141101

Group type: EXPERIMENTAL
Intervention: Attention problems in both grades (persistent attention problems)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attention problems in first grade only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attention problems emerging in second grade
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison children
Number of subjects: 0
Study: 25315237

Group type: EXPERIMENTAL
Intervention: Lifestyle Advice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 0
Study: 22825900

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aerosolized iloprost
Number of subjects: 16
Study: 19793929

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal
Number of subjects: 42
Study: 17074329

Group type: EXPERIMENTAL
Intervention: Clearblue Easy Fertility Monitor (CEFM)
Number of subjects: 653

Group type: COMPARATOR
Intervention: Control (no CEFM)
Number of subjects: 653
Study: 16282697

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/day from 2 days after surgery
Number of subjects: 24

Group type: COMPARATOR
Intervention: No antithrombotic therapy
Number of subjects: 24
Study: 14662211

Group type: EXPERIMENTAL
Intervention: Corticosteroids (intravenous methylprednisolone 125 mg followed by oral prednisone taper: 40 mg for 1 day, 20 mg for 3 days, 10 mg for 3 days, 5 mg for 7 days)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo (identical-appearing regimen)
Number of subjects: 126
Study: 10711607

Group type: EXPERIMENTAL
Intervention: Double pedicle flaps (DPF)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Apically positioned flaps (APF)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Free gingival grafts (FGG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (untreated sites)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Preoperative periodontal parameters
Number of subjects: 29
Study: 9377140

Group type: EXPERIMENTAL
Intervention: Heel stick
Number of subjects: 27

Group type: COMPARATOR
Intervention: Venepuncture
Number of subjects: 27
Study: 7967324

Group type: EXPERIMENTAL
Intervention: Penbutolol
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 64

Group type: COMPARATOR
Intervention: Acebutolol
Number of subjects: 64
Study: 3519097

Group type: EXPERIMENTAL
Intervention: 600 mg fipexide daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30356442

Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study: 27449221

Group type: EXPERIMENTAL
Intervention: Kunxian capsules (0.6 g, three times per day) for 12 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Kunxian capsules
Number of subjects: 80
Study: 24958498

Group type: EXPERIMENTAL
Intervention: Full-mouth periodontal scaling during a single visit
Number of subjects: 273

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 273
Study: 22379070

Group type: EXPERIMENTAL
Intervention: Sputum induction in children with severe asthma (n=42)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Sputum induction in children with mild to moderate asthma (n=17)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Sputum induction in children with asthma (both groups)
Number of subjects: 79
Study: 20382279

Group type: EXPERIMENTAL
Intervention: Electric stimulation (ES) combined with active ankle dorsiflexion while standing on a rocker board
Number of subjects: 15

Group type: COMPARATOR
Intervention: General range of motion and strength exercises
Number of subjects: 15
Study: 18427362

Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection (FMD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional quadrant therapy
Number of subjects: 20
Study: 16167471

Group type: EXPERIMENTAL
Intervention: Synbiotic 2000 (four different lactobacilli preparations with 10^10 CFU and prebiotics)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Synbiotic 2000
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (only prebiotics)
Number of subjects: 62
Study: 12598350

Group type: EXPERIMENTAL
Intervention: Alternating regimen (docetaxel 100 mg/m2, doxorubicin 75 mg/m2, cycle-by-cycle alternating)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Sequential regimen (docetaxel 100 mg/m2, doxorubicin 75 mg/m2, sequential for four cycles)
Number of subjects: 106
Study: 10492276

Group type: EXPERIMENTAL
Intervention: 99mTc DTPA aerosol inhalation lung scintigraphy
Number of subjects: 13
Study: 8894572

Group type: EXPERIMENTAL
Intervention: 1 g cefaclor
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Comparison of both groups
Number of subjects: 39
Study: 1856932

Group type: EXPERIMENTAL
Intervention: Temporary occlusion of hypogastric arteries
Number of subjects: 130

Group type: COMPARATOR
Intervention: No temporary occlusion of hypogastric arteries
Number of subjects: 130
Study: 6357076

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Carboxypenicillin-aminoglycoside combination
Number of subjects: 50
Study: 31215755

Group type: EXPERIMENTAL
Intervention: Verubecestat (100 mg single dose or 30, 80, and 120 mg multiple doses once daily for 28 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27555381

Group type: EXPERIMENTAL
Intervention: atDCS+SSRI
Number of subjects: 40

Group type: COMPARATOR
Intervention: atDCS+placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: sham+placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: sham+SSRI
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SSRI
Number of subjects: 40
Study: 25978402

Group type: EXPERIMENTAL
Intervention: PASSAGE Program (intervention group)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Waitlist Group (control)
Number of subjects: 43
Study: 22676966

Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 30
Study: 21239979

Group type: EXPERIMENTAL
Intervention: Watchful waiting management
Number of subjects: 336
Study: 18780164

Group type: EXPERIMENTAL
Intervention: Controlled release formulation with immediate release element
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Four formulations of Galantamine
Number of subjects: 4
Study: 16429213

Group type: EXPERIMENTAL
Intervention: Soy formula with fiber (SF)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Cow's milk-based formula (CM)
Number of subjects: 179
Study: 15333386

Group type: EXPERIMENTAL
Intervention: Surface‐rewarming group (using the Arctic Sun thermoregulatory system; n = 7)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control standard rewarming group (n = 6)
Number of subjects: 13
Study: 10695942

Group type: EXPERIMENTAL
Intervention: Metronidazole 250 mg plus Amoxicillin 500 mg (M+A)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 9343284

Group type: EXPERIMENTAL
Intervention: Hypoantigenic milk formula
Number of subjects: 36

Group type: COMPARATOR
Intervention: Breastfeeding
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional formula feeding
Number of subjects: 36
Study: 8404931

Group type: EXPERIMENTAL
Intervention: Early plasma atrial natriuretic factor (ANF) levels
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Early plasma atrial natriuretic factor (ANF) levels in patients without effort-associated ischaemia
Number of subjects: 90
Study: 3633511

Group type: EXPERIMENTAL
Intervention: External pneumatic intermittent compression (EPIC) for 30 minutes at 40 torr
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no EPIC)
Number of subjects: 35
Study: 29695370

Group type: EXPERIMENTAL
Intervention: Hinge Health digital care program for chronic knee pain (12-week intervention including sensor-guided exercise therapy, education, cognitive behavioral therapy, weight loss, and psychosocial support)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Hinge Health digital care program for chronic knee pain
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Hinge Health digital care program for chronic knee pain (per protocol analysis)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (received three education pieces regarding self-care for chronic knee pain)
Number of subjects: 162
Study: 28863052

Group type: EXPERIMENTAL
Intervention: Home telehealth and motivational interviewing (MI) counseling
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group smoking cessation assistance
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups' experiences
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Home telehealth and MI
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Support and increased awareness of smoking behaviors
Number of subjects: 32
Study: 25829397

Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Cycle 3 EGFR mut(+) cfDNA
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Cycle 3 EGFR mut(−) cfDNA
Number of subjects: 238
Study: 23109243

Group type: EXPERIMENTAL
Intervention: Peripheral Blood Stem Cell (PBSC) donation
Number of subjects: 9494

Group type: COMPARATOR
Intervention: Bone Marrow (BM) donation
Number of subjects: 9494
Study: 21530339

Group type: EXPERIMENTAL
Intervention: Lidocaine patch (5%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 0
Study: 18975369

Group type: EXPERIMENTAL
Intervention: Febuxostat 80 mg
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Febuxostat 120 mg
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Febuxostat 240 mg
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Allopurinol (300 or 100 mg)
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Febuxostat 80 mg (impaired renal function)
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Febuxostat 120 mg (impaired renal function)
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Febuxostat 240 mg (impaired renal function)
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Allopurinol 100 mg (impaired renal function)
Number of subjects: 1072
Study: 16472565

Group type: EXPERIMENTAL
Intervention: Tranexamic acid 500 mg twice a day for 5 days
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 12577155

Group type: EXPERIMENTAL
Intervention: Minimally invasive airway suctioning (MIAS)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Routine endotracheal suctioning (RES)
Number of subjects: 208
Study: 11141229

Group type: EXPERIMENTAL
Intervention: Clinafloxacin
Number of subjects: 529

Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 529
Study: 9741041

Group type: EXPERIMENTAL
Intervention: Objective binge episodes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjective binge episodes
Number of subjects: 0
Study: 7977957

Group type: EXPERIMENTAL
Intervention: Resection plus elective supraomohyoid neck dissection (RSOND)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Resection alone (RA)
Number of subjects: 67
Study: 2498657

Group type: EXPERIMENTAL
Intervention: Prophylactic surgical ligation of the ductus arteriosus on the day of birth (n = 40)
Number of subjects: 84
Study: 31981802

Group type: EXPERIMENTAL
Intervention: Anxiety Sensitivity Amelioration Program for Youth (ASAP-Y)
Number of subjects: 88

Group type: COMPARATOR
Intervention: General health information control condition
Number of subjects: 88
Study: 28409233

Group type: EXPERIMENTAL
Intervention: Web-based intervention (WBI)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Printed manual intervention (PMI)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both WBI and PMI
Number of subjects: 84
Study: 25776839

Group type: EXPERIMENTAL
Intervention: Curcumin (1 g/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21142787

Group type: EXPERIMENTAL
Intervention: Etching with CO(2) laser
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sandblasting with 50‐μm Al(2)O(3)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Coating with titanium nitride (TiAlN)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Silicoating by Silano‐Pen
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (unaltered abutments)
Number of subjects: 50
Study: 20828371

Group type: EXPERIMENTAL
Intervention: Propranolol (PROP, n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CTRL, n=10)
Number of subjects: 20
Study: 20108651

Group type: EXPERIMENTAL
Intervention: Benidipine
Number of subjects: 236

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 236
Study: 17953475

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil/HCTZ (40/12.5 mg/day for 4 weeks; then 40/25 mg/day for 4 weeks)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Benazepril plus amlodipine besylate (20/5 mg/day for 4 weeks; then 20/10 mg/day for 4 weeks)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil/HCTZ
Number of subjects: 190

Group type: COMPARATOR
Intervention: Benazepril plus amlodipine besylate
Number of subjects: 190
Study: 15492993

Group type: EXPERIMENTAL
Intervention: Annual mammography from age 40
Number of subjects: 160861

Group type: COMPARATOR
Intervention: Control group (no annual mammography)
Number of subjects: 160861
Study: 11209625

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol
Number of subjects: 205

Group type: COMPARATOR
Intervention: Intracervical Foley catheter
Number of subjects: 205

Group type: COMPARATOR
Intervention: Combination prostaglandin E2 (PGE2) gel and Foley catheter
Number of subjects: 205
Study: 9573676

Group type: EXPERIMENTAL
Intervention: Delayed intensification therapy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard treatment without delayed intensification therapy
Number of subjects: 108
Study: 7826905

Group type: EXPERIMENTAL
Intervention: alpha-IFN
Number of subjects: 177

Group type: COMPARATOR
Intervention: splenectomy after achieving PR
Number of subjects: 177
Study: 29979362

Group type: EXPERIMENTAL
Intervention: Prineo closure (octyl-2-cyanoacrylate and adhesive mesh)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Subcuticular closure
Number of subjects: 21
Study: 27171112

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (2800 International Units per day for 8 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 24774351

Group type: EXPERIMENTAL
Intervention: HOPE intervention
Number of subjects: 242

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 242
Study: 22542605

Group type: EXPERIMENTAL
Intervention: 6‐mercaptopurine (0.5‐1.5mg/kg/day, n=30)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Elental as an elemental diet (≥900 kcal/day, n=32)
Number of subjects: 95

Group type: COMPARATOR
Intervention: None (control, n=33)
Number of subjects: 95